Business
Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing
Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing\n \n \nEaston Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing\n \n TORONTO, ON--(Marketwired - Mar 3, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has revised its offer to Vodis Innovative Pharmaceuticals in the companies quest to close on an acceptable agreement towards its medical marijuana initiatives. Additionally, Easton has signed a Letter of Intent with a private Ontario Canada based company presently producing organic medical marijuana, as well as executing an additional letter of intent towards a partnership agreement for the purchase of various marijuana producing companies who have all filed applications with health Canada for medical marijuana distribution and growing licenses under the MMPR (Medical Marijuana For Medical Purposes Regulations) which includes a revenue producing acquisition. \n In order to keep its shareholders abreast on initiatives, Easton has decided to announce it has been in negotiations with Vodis Innovative pharmaceuticals, a private British Columbia based company who have received pre license approval on medical marijuana from health Canada under MMPR regulations. Vodis is considered to be one of only 8 companies thus far who have received approval, but who now are mandated to meet and pass certification on facilities as per their application prior to receiving a license. Vodis is considered an established producer of marijuana and have received awards for their quality of cannabis and are considered to possess high technology growing equipment including LED lighting. Vodis continues to be in negotiations with Easton pharmaceuticals to work towards what is hoped to be a final agreement. Easton Pharmaceuticals previously forwarded an initial proposal which was revised on...